International travel during cancer treatment: a continuity plan

Give the responsible oncologist or specialist nurse the real dates, every destination and transit, transport duration, accommodation, planned activity and distance from appropriate care. Ask whether the trip timing conflicts with chemotherapy, radiotherapy, immunotherapy, surgery, blood tests, infusions, recovery or follow-up, and obtain a personal written decision rather than copying another patient's experience. Cancer Research UK notes that whether someone can travel depends on the cancer, treatment and how they feel. This page cannot decide fitness, delay or move treatment, estimate personal infection or clot risk, interpret results, or approve a destination. If the clinical answer is no, uncertain or conditional on a review not yet completed, stop the travel decision.

List each prescribed medicine, supportive treatment, injection, dressing, line or stoma supply and monitoring device with exact name, strength, schedule, storage and responsible contact. Obtain the clinician-approved quantity and contingency, original labelled packaging where required, and only the necessary prescription or medical letter. Verify import, transit, screening and carrier rules with each competent authority; an EU cross-border prescription has required information but does not guarantee that a medicine exists locally. Keep temperature control, sharps, batteries and the only supply under manufacturer, pharmacy, carrier and security instructions. Do not alter a dose, treatment date or storage method, share medicine, conceal equipment or rely on an unverified overseas seller.

Ask the oncology team which personal signs or measured changes require same-day or emergency action, whether treatment changes vaccine or infection precautions, and which activities, food, water, crowds, sun, swimming or animal exposure need an individual restriction. Macmillan advises discussing travel vaccinations with the cancer doctor because some are not suitable during or after certain treatments, but generic guidance cannot classify this traveller's immune status. Identify an appropriate destination facility, insurer authorization route and conventional emergency channel before departure. Keep a private offline summary of diagnosis, treatment, medicines, allergies, devices, recent results selected by the team and contacts. Never wait for an app or data signal when the written clinical plan says to seek care.

Agree who to contact for fever, new bleeding, breathing difficulty, uncontrolled pain, vomiting or diarrhoea, line or wound problems, medicine loss, device failure or any treatment-specific warning named by the care team. Record local emergency numbers, the selected facility, insurer process, transport fallback, companion roles and how the oncology service will receive information. Decide how an early return, delayed return or hospital admission changes the next appointment and medicine supply, without assuming an airline, insurer or consulate will provide medical transport. Use conventional calls or in-person help where required and keep essential documents accessible without unlocking a lost phone. This connectivity guide does not diagnose deterioration, set temperature thresholds or promise evacuation, admission, payment or continuity of care.

Only after oncology approval, treatment and supply handoffs, personal precautions and the offline deterioration route are resolved should you list non-critical tasks such as opening an authenticated booking, viewing an ordinary map or checking an address already selected by the care team. Subtract saved documents, confirmed home roaming and trusted Wi-Fi, then estimate only the remainder. Continue only with an unlocked compatible phone, every visited country listed, and suitable activation, validity, allowance and public service facts. Stop if the need is treatment advice, monitoring, an urgent call, medicine access, a local number, calls, SMS or guaranteed reception. CheapESIM inventory is ordinary phone data, not cancer care.